MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹549 Cr | ₹405 Cr | ₹422 Cr | ₹270 Cr | ₹221 Cr |
What is the latest Total Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹549 Cr |
| Mar2024 | ₹405 Cr |
| Mar2023 | ₹422 Cr |
| Mar2022 | ₹270 Cr |
| Mar2021 | ₹221 Cr |
How is Total Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹549 Cr | 35.50 | |
| Mar2024 | ₹405 Cr | -4.02 | |
| Mar2023 | ₹422 Cr | 56.03 | |
| Mar2022 | ₹270 Cr | 22.36 | |
| Mar2021 | ₹221 Cr | - | |
Compare Total Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹477.9 Cr | -1.3% | -7% | 19.2% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,797.2 Cr | -3.7% | -0.5% | -12.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,034.1 Cr | 5.1% | 0.7% | 12.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,090.8 Cr | 5.6% | 10.7% | -17.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,160.4 Cr | 10% | 0.3% | -23.4% | Stock Analytics | |
| INDO US BIOTECH | ₹245.7 Cr | -0.5% | -7.4% | -63.5% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -1.3% |
-7% |
19.2% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses